- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05107180
cl[Nical Study of Succide Among Patient With Psychoactive Substance Use Disorders
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Substance use disorder (or drug addiction) is a neuropsychiatric disorder characterized by recurring desire to continue taking the drug despite harmful consequences. Substance use disorders are a major risk factor for suicide Suicide is a leading cause of premature death in young adults. Data from the World Health Organization indicate that the rate of completed suicide for the world's population is 16 per 100,000 inhabitants, which means that each year more than a million people in the world commit suicide. Suicide attempts are five to twenty times more common than the completed suicide.Based on the data from the research community, approximately 5% of adults attempts suicide at least once in their lifetime .
Mental health problems are the most common and best explored risk factor associated suicidal ideas, suicide attempts and completed suicide. About 90% of all people who commit suicide met the diagnostic criteria for one or more psychiatric disorders . People who use alcohol and/or drugs or are dependent on them, attempting suicide nearly six times more often than people who do not use these substances. The rate of completed suicide among addicts is 2 to 3 times higher than among the males who are not addictst, while in a few cases the manner in which the suicide is attempted is not directly related to drugs . Although there is a correlation between the disorder caused by the use of substances and suicidal behavior, a large number of addicts will never attempt suicide. It is therefore important to identify those individuals with the disorder caused by the use of substances that may be at higher risk for suicide .
Many risk factors for suicide in the general population also apply to drug addicts. The older drug addicts are at higher risk for attempts and suicides than younger addicts Another very important fact when it comes to suicide attempts is the drug used. It is known that heroin and sedatives are substances with which suicide attempts suicide are most often made, while other drugs are less characteristic .
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Contact
- Name: hebat allah hassan goda
- Phone Number: 01090200687
- Email: hebagoda119@gmail.com
Study Contact Backup
- Name: wageh abd elnaser
- Phone Number: 01227432194
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
Patients fulfilling diagnostic criteria of substance use disorder
- social impairment
- impaired control
- risky use
- pharmacological indicators (tolerance and withdrawal).
Exclusion Criteria:
- Patient with other psychatric disorders ex schizophrenia, mood disorder
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Prevelance of suicide and suicide tendancy in patients with substance use disorders.
Time Frame: 6 months
|
observation and study of prevelance of suicide among patient with substance use disorders
|
6 months
|
|
Detect risk factors for suicide and in patients with substance use disorder.
Time Frame: 6 months
|
observation of patient
|
6 months
|
Collaborators and Investigators
Sponsor
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Anticipated)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- succide among drug addict
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Substance Use Disorders
-
University of ArkansasNational Center for Advancing Translational Sciences (NCATS)RecruitingParenting | Substance Use Treatment | Perinatal Substance UseUnited States
-
Emory UniversityNational Institute on Drug Abuse (NIDA); Georgia Institute of Technology; CUNYCompletedSubstance-Related Disorders | Substance Abuse, Intravenous | Substance Use Disorders | Opioid Use | Substance Abuse | Opioid-use Disorder | Opioid Use Disorder, Severe | Substance WithdrawalUnited States
-
Medical University of South CarolinaNational Institute on Drug Abuse (NIDA)RecruitingTobacco Use | Substance Use DisordersUnited States
-
Wake Forest University Health SciencesNational Institute on Drug Abuse (NIDA)CompletedSubstance Use | Opioid Use | Drug Use | Substance MisuseUnited States
-
Medical University of South CarolinaNational Institute on Drug Abuse (NIDA)RecruitingSubstance Use | Substance Use Disorders | Cannabis Use | Alcohol Use, UnspecifiedUnited States
-
Woebot HealthNational Institute on Drug Abuse (NIDA); Stanford UniversityCompletedSubstance Use Disorders | Alcohol Use Disorder (AUD)United States
-
University of California, San FranciscoTobacco Related Disease Research ProgramRecruitingTobacco Use Disorder | Substance Use Disorder (SUD)United States
-
Icahn School of Medicine at Mount SinaiNational Institute on Drug Abuse (NIDA)Active, not recruitingSubstance Use Disorder | Cocaine Use DisorderUnited States
-
University of Illinois at ChicagoNot yet recruitingHealthy | Cannabis Use | Substance Use Disorder (SUD)United States
-
Indiana UniversityNational Institute on Drug Abuse (NIDA)RecruitingSubstance Use Disorders | Nicotine Use DisorderUnited States
Clinical Trials on drug screen
-
Sheffield Teaching Hospitals NHS Foundation TrustUniversity of SheffieldRecruitingMelanoma | Sarcoma | Kidney Cancer | Head and Neck Cancer | Glioblastoma | Bladder CancerUnited Kingdom
-
Shanghai Zhongshan HospitalRecruiting
-
Oncosyne ASUniversity Hospital, Akershus; CTC Clinical Trial Consultants ABRecruitingMetastatic Colorectal Cancer (mCRC)Norway
-
Chinese University of Hong KongUnknownColorectal Neoplasms | Colon Adenoma | Colon PolypHong Kong
-
Theodore MacnowCompleted
-
Allen A. Greiner, MD, MPHNational Institutes of Health (NIH)CompletedColorectal CancerUnited States
-
University of Southern DenmarkEuropean Research CouncilCompleted
-
Kahramanmaras Sutcu Imam UniversityActive, not recruitingParent-Child Relational Problem | Screen Media Use | Problematic Media UseTurkey (Türkiye)
-
University of South FloridaActive, not recruiting
-
Alaska Blind Child DiscoveryCompletedStrabismus | Strabismic Amblyopia | Refractive AmblyopiaUnited States